PNC Financial Services Group’s Gracell Biotechnologies Inc. American Depositary Shares GRCL Stock Holding History

PNC Financial Services Group’s Portfolio GRCL Stock Details GRCL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-150	Closed	-$1.51K	–	4859
2023 Q4	$1.51K	Hold	150	–	–	﹤0.01%	4236
2023 Q3	$432	Buy	+150	New	+$548	﹤0.01%	4479

PNC Financial Services Group's GRCL Position: Q1 2024 in Review

PNC Financial Services Group sold out of Gracell Biotechnologies Inc. American Depositary Shares (GRCL) in Q1 2024, closing a stake of 150 shares — an estimated $1.51K sold.

PNC Financial Services Group first reported a position in GRCL in Q3 2023 and held it in 2 quarters. The position peaked at $1.51K in Q4 2023. 0 funds tracked by Wall St. Rank hold GRCL as of Q1 2024.

PNC Financial Services Group reported no remaining Gracell Biotechnologies Inc. American Depositary Shares position as of Q1 2024 after selling out during the quarter.
PNC Financial Services Group sold 150 Gracell Biotechnologies Inc. American Depositary Shares shares in Q1 2024, an estimated $1.51K.
PNC Financial Services Group first reported a position in Gracell Biotechnologies Inc. American Depositary Shares in Q3 2023 and held it in 2 quarters.
PNC Financial Services Group's Gracell Biotechnologies Inc. American Depositary Shares position peaked at $1.51K in Q4 2023.
0 funds tracked by Wall St. Rank held Gracell Biotechnologies Inc. American Depositary Shares as of Q1 2024.

Based on PNC Financial Services Group's 13F filing for Q1 2024, filed 10 May 2024.